Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Read

Showing results (631-640 of 718) with videos related to

Pageof 72
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2024
Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolismA Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, et al.
Blood Purification|September 13, 2021
Adjunct Use of Continuous Renal Replacement Therapy with Extracorporeal Membrane Oxygenation Achieves Negative Fluid Balance and Enhances Oxygenation Which Improves Survival in Critically Ill Patients without Kidney FailureJason M Thomas, David N Dado, Anthony P Basel, et al.
Chemmedchem|September 24, 2015
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding ModeDaniel Spinks, Victoria Smith, Stephen Thompson, et al.
Malaria Journal|June 8, 2011
Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in miceGeoffrey S Dow, Erin Milner, Ian Bathurst, et al.
ACS Medicinal Chemistry Letters|January 24, 2014
Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type ReceptorTonia Aristotelous, Seungkirl Ahn, Arun K Shukla, et al.
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
The Journal of Infectious Diseases|February 13, 2026
Variable Staphylothrombin Activity in Staphylococcus aureus Bloodstream InfectionsGregory L Damhorst, Madeline J Boulis, Elizabeth B Nelson, et al.
ACS Chemical Biology|June 18, 2025
High-Throughput Screening of Potent Drug-like Molecules Targeting 17β-HSD10 for the Treatment of Alzheimer's Disease and CancerLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Communications Biology|August 3, 2019
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolitesShaowei Zhang, Michiyo Sakuma, Girdhar S Deora, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Pageof 72

Showing results (631-640 of 718) with videos related to

Sort By:
Pageof 72
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2024
Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolismA Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, et al.
Blood Purification|September 13, 2021
Adjunct Use of Continuous Renal Replacement Therapy with Extracorporeal Membrane Oxygenation Achieves Negative Fluid Balance and Enhances Oxygenation Which Improves Survival in Critically Ill Patients without Kidney FailureJason M Thomas, David N Dado, Anthony P Basel, et al.
Chemmedchem|September 24, 2015
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding ModeDaniel Spinks, Victoria Smith, Stephen Thompson, et al.
Malaria Journal|June 8, 2011
Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in miceGeoffrey S Dow, Erin Milner, Ian Bathurst, et al.
ACS Medicinal Chemistry Letters|January 24, 2014
Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type ReceptorTonia Aristotelous, Seungkirl Ahn, Arun K Shukla, et al.
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
The Journal of Infectious Diseases|February 13, 2026
Variable Staphylothrombin Activity in Staphylococcus aureus Bloodstream InfectionsGregory L Damhorst, Madeline J Boulis, Elizabeth B Nelson, et al.
ACS Chemical Biology|June 18, 2025
High-Throughput Screening of Potent Drug-like Molecules Targeting 17β-HSD10 for the Treatment of Alzheimer's Disease and CancerLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Communications Biology|August 3, 2019
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolitesShaowei Zhang, Michiyo Sakuma, Girdhar S Deora, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Pageof 72